CervoMed Inc. Company Profile
NASDAQ: CRVOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 3:59 PM ET · Delayed 15 min
CervoMed at a glance
CervoMed Inc. (NASDAQ: CRVO) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Boston, MA. CervoMed is led by Dr. John J. Alam M.D. and employs about 15 people. At a market capitalization of $49.6 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001053691, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does CervoMed do?
CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the bloodbrain barrier and inhibits the enzyme p38a. Neflamapimod has the potential to reverse synaptic dysfunction, improve neuron health, and slow or prevent disease progression. Neflamapimod is currently in clinical development for the treatment of dementia with Lewy bodies, non-fluent variant primary progressive aphasia, amyotrophic lateral sclerosis, and amyotrophic lateral sclerosis. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.
Business description based on the company's public filings.
Company information
- Legal name
- CervoMed Inc.
- Ticker
- NASDAQ: CRVO
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Dr. John J. Alam M.D.
- Employees
- 15
- Headquarters
- 20 Park Plaza, Boston, MA, United States
- Phone
- 617 744 4400
- Website
- cervomed.com
- Market cap
- $49.59M
- SEC CIK
- 0001053691
- Latest annual report
- 10-K · Mar 13, 2026
Companies similar to CervoMed
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ELTXElicio Therapeutics Inc. | 1.89 | +4.42% | $49.67M | vs CRVO |
| CELUCelularity Inc. Class A | 1.56 | +6.90% | $50.62M | vs CRVO |
| SERSerina Therapeutics Inc. | 2.00 | -0.50% | $50.80M | vs CRVO |
| HOWLWerewolf Therapeutics Inc. | 0.9796 | +7.65% | $47.61M | vs CRVO |
| DWTXDogwood Therapeutics Inc. | 1.40 | -0.71% | $47.59M | vs CRVO |
| HYPDHyperion DeFi Inc. | 3.40 | +1.04% | $51.69M | vs CRVO |
| EDSAEdesa Biotech Inc. | 3.51 | -4.10% | $47.43M | vs CRVO |
| ANVSAnnovis Bio Inc. | 1.22 | +4.27% | $52.07M | vs CRVO |